Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Hypocomplementemic urticarial vasculitis syndrome with gastrointestinal vasculitis and crescentic membranoproliferative glomerulonephritis without immune complex deposits.

Ueki K, Tsuchimoto A, Matsukuma Y, Torisu K, Fujisaki K, Torisu T, Yamada Y, Oda Y, Masutani K, Nakano T, Tsuruya K, Kitazono T.

CEN Case Rep. 2019 Oct 4. doi: 10.1007/s13730-019-00421-4. [Epub ahead of print]

2.

Association of Lower Serum Bilirubin With Loss of Residual Kidney Function in Peritoneal Dialysis Patients.

Tsujikawa H, Tanaka S, Hara M, Kawai Y, Matsukuma Y, Torisu K, Nakano T, Tsuruya K, Kitazono T.

Ther Apher Dial. 2019 Jun 17. doi: 10.1111/1744-9987.12865. [Epub ahead of print]

PMID:
31207066
3.

Rapidly Progressive Glomerulonephritis with Delayed Appearance of Anti-Glomerular Basement Membrane Antibody Successfully Treated with Multiple Courses of Steroid Pulse Therapy.

Toyota S, Eriguchi M, Hasegawa S, Ueki K, Matsukuma Y, Tsuchimoto A, Fujisaki K, Torisu K, Tsuruya K, Nakano T, Kitazono T.

Case Rep Nephrol Dial. 2019 Apr 16;9(1):25-32. doi: 10.1159/000499401. eCollection 2019 Jan-Apr.

4.

Development of a risk prediction model for infection-related mortality in patients undergoing peritoneal dialysis.

Tsujikawa H, Tanaka S, Matsukuma Y, Kanai H, Torisu K, Nakano T, Tsuruya K, Kitazono T.

PLoS One. 2019 Mar 20;14(3):e0213922. doi: 10.1371/journal.pone.0213922. eCollection 2019.

5.

Prognostic value of pre-dialysis blood pressure and risk threshold on clinical outcomes in hemodialysis patients: The Q-Cohort Study.

Hara M, Tanaka S, Taniguchi M, Fujisaki K, Torisu K, Masutani K, Hirakata H, Nakano T, Tsuruya K, Kitazono T.

Medicine (Baltimore). 2018 Dec;97(51):e13485. doi: 10.1097/MD.0000000000013485.

6.

Adrenal crisis presented as acute onset of hypercalcemia and hyponatremia triggered by acute pyelonephritis in a patient with partial hypopituitarism and pre-dialysis chronic kidney disease.

Yamada S, Arase H, Morishita T, Tsuchimoto A, Torisu K, Torisu T, Tsuruya K, Nakano T, Kitazono T.

CEN Case Rep. 2019 May;8(2):83-88. doi: 10.1007/s13730-018-0371-9. Epub 2018 Nov 19.

7.

Association between serum albumin level and incidence of end-stage renal disease in patients with Immunoglobulin A nephropathy: A possible role of albumin as an antioxidant agent.

Kawai Y, Masutani K, Torisu K, Katafuchi R, Tanaka S, Tsuchimoto A, Mitsuiki K, Tsuruya K, Kitazono T.

PLoS One. 2018 May 24;13(5):e0196655. doi: 10.1371/journal.pone.0196655. eCollection 2018.

8.

Hemoglobin concentration and the risk of hemorrhagic and ischemic stroke in patients undergoing hemodialysis: the Q-cohort study.

Yotsueda R, Tanaka S, Taniguchi M, Fujisaki K, Torisu K, Masutani K, Hirakata H, Kitazono T, Tsuruya K.

Nephrol Dial Transplant. 2018 May 1;33(5):856-864. doi: 10.1093/ndt/gfx305.

PMID:
29237088
9.

Vascular endothelial growth factor-C ameliorates renal interstitial fibrosis through lymphangiogenesis in mouse unilateral ureteral obstruction.

Hasegawa S, Nakano T, Torisu K, Tsuchimoto A, Eriguchi M, Haruyama N, Masutani K, Tsuruya K, Kitazono T.

Lab Invest. 2017 Dec;97(12):1439-1452. doi: 10.1038/labinvest.2017.77. Epub 2017 Oct 30.

10.

Autophagy promotes degradation of internalized collagen and regulates distribution of focal adhesions to suppress cell adhesion.

Kawano S, Torisu T, Esaki M, Torisu K, Matsuno Y, Kitazono T.

Biol Open. 2017 Nov 15;6(11):1644-1653. doi: 10.1242/bio.027458.

11.

Cardiothoracic Ratio and All-Cause Mortality and Cardiovascular Disease Events in Hemodialysis Patients: The Q-Cohort Study.

Yotsueda R, Taniguchi M, Tanaka S, Eriguchi M, Fujisaki K, Torisu K, Masutani K, Hirakata H, Kitazono T, Tsuruya K.

Am J Kidney Dis. 2017 Jul;70(1):84-92. doi: 10.1053/j.ajkd.2016.11.026. Epub 2017 Feb 10.

PMID:
28196648
12.

Deficiency of base excision repair enzyme NEIL3 drives increased predisposition to autoimmunity.

Massaad MJ, Zhou J, Tsuchimoto D, Chou J, Jabara H, Janssen E, Glauzy S, Olson BG, Morbach H, Ohsumi TK, Schmitz K, Kyriacos M, Kane J, Torisu K, Nakabeppu Y, Notarangelo LD, Chouery E, Megarbane A, Kang PB, Al-Idrissi E, Aldhekri H, Meffre E, Mizui M, Tsokos GC, Manis JP, Al-Herz W, Wallace SS, Geha RS.

J Clin Invest. 2016 Nov 1;126(11):4219-4236. doi: 10.1172/JCI85647. Epub 2016 Oct 17.

13.

A J-shaped association between serum uric acid levels and poor renal survival in female patients with IgA nephropathy.

Matsukuma Y, Masutani K, Tanaka S, Tsuchimoto A, Fujisaki K, Torisu K, Katafuchi R, Hirakata H, Tsuruya K, Kitazono T.

Hypertens Res. 2017 Mar;40(3):291-297. doi: 10.1038/hr.2016.134. Epub 2016 Oct 13.

PMID:
27733763
14.

PKCĪ· deficiency improves lipid metabolism and atherosclerosis in apolipoprotein E-deficient mice.

Torisu K, Zhang X, Nonaka M, Kaji T, Tsuchimoto D, Kajitani K, Sakumi K, Torisu T, Chida K, Sueishi K, Kubo M, Hata J, Kitazono T, Kiyohara Y, Nakabeppu Y.

Genes Cells. 2016 Oct;21(10):1030-1048. doi: 10.1111/gtc.12402. Epub 2016 Aug 22.

15.

Intact endothelial autophagy is required to maintain vascular lipid homeostasis.

Torisu K, Singh KK, Torisu T, Lovren F, Liu J, Pan Y, Quan A, Ramadan A, Al-Omran M, Pankova N, Boyd SR, Verma S, Finkel T.

Aging Cell. 2016 Feb;15(1):187-91. doi: 10.1111/acel.12423. Epub 2015 Nov 24.

16.

Extended Swan-Neck Catheter With Upper Abdominal Exit-Site Reduces Peritoneal Dialysis-Related Infections.

Eriguchi M, Tsuruya K, Yoshida H, Haruyama N, Tanaka S, Tsuchimoto A, Fujisaki K, Torisu K, Masutani K, Kitazono T.

Ther Apher Dial. 2016 Apr;20(2):158-64. doi: 10.1111/1744-9987.12358. Epub 2016 Jan 14.

PMID:
26762798
17.

Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.

Eriguchi M, Yotsueda R, Torisu K, Kawai Y, Hasegawa S, Tanaka S, Noguchi H, Masutani K, Kitazono T, Tsuruya K.

Am J Physiol Renal Physiol. 2016 Feb 15;310(4):F322-33. doi: 10.1152/ajprenal.00260.2015. Epub 2015 Dec 2.

18.

Membranoproliferative glomerulonephritis with predominant IgG2 and IgG3 deposition in a patient with IgG4-related disease.

Ueki K, Matsukuma Y, Masutani K, Tsuchimoto A, Fujisaki K, Torisu K, Tanaka S, Kiyoshima T, Hisano S, Kitazono T, Tsuruya K.

BMC Nephrol. 2015 Oct 26;16:173. doi: 10.1186/s12882-015-0164-8.

19.

Spironolactone ameliorates arterial medial calcification in uremic rats: the role of mineralocorticoid receptor signaling in vascular calcification.

Tatsumoto N, Yamada S, Tokumoto M, Eriguchi M, Noguchi H, Torisu K, Tsuruya K, Kitazono T.

Am J Physiol Renal Physiol. 2015 Dec 1;309(11):F967-79. doi: 10.1152/ajprenal.00669.2014. Epub 2015 Sep 2.

20.

Characterization of the structure and expression of mouse Itpa gene and its related sequences in the mouse genome.

Behmanesh M, Sakumi K, Tsuchimoto D, Torisu K, Ohnishi-Honda Y, Rancourt DE, Nakabeppu Y.

DNA Res. 2015 Apr;22(2):181. doi: 10.1093/dnares/dsv006. No abstract available.

21.

Improvement in spatial memory dysfunction by telmisartan through reduction of brain angiotensin II and oxidative stress in experimental uremic mice.

Haruyama N, Fujisaki K, Yamato M, Eriguchi M, Noguchi H, Torisu K, Tsuruya K, Kitazono T.

Life Sci. 2014 Sep 15;113(1-2):55-9. doi: 10.1016/j.lfs.2014.07.032. Epub 2014 Aug 10.

PMID:
25107329
22.

Renal denervation has blood pressure-independent protective effects on kidney and heart in a rat model of chronic kidney disease.

Eriguchi M, Tsuruya K, Haruyama N, Yamada S, Tanaka S, Suehiro T, Noguchi H, Masutani K, Torisu K, Kitazono T.

Kidney Int. 2015 Jan;87(1):116-27. doi: 10.1038/ki.2014.220. Epub 2014 Jun 18.

23.

Autophagy regulates endothelial cell processing, maturation and secretion of von Willebrand factor.

Torisu T, Torisu K, Lee IH, Liu J, Malide D, Combs CA, Wu XS, Rovira II, Fergusson MM, Weigert R, Connelly PS, Daniels MP, Komatsu M, Cao L, Finkel T.

Nat Med. 2013 Oct;19(10):1281-7. doi: 10.1038/nm.3288. Epub 2013 Sep 22.

24.

Suppressor of cytokine signaling 1 protects mice against concanavalin A-induced hepatitis by inhibiting apoptosis.

Torisu T, Nakaya M, Watanabe S, Hashimoto M, Yoshida H, Chinen T, Yoshida R, Okamoto F, Hanada T, Torisu K, Takaesu G, Kobayashi T, Yasukawa H, Yoshimura A.

Hepatology. 2008 May;47(5):1644-54. doi: 10.1002/hep.22214.

PMID:
18393318
25.

A simplified, sensitive immunohistochemical detection system employing signal amplification based on fluorescyl-tyramide/antifluorescein antibody reaction: its application to pathologic testing and research.

Hatanaka Y, Imaoka Y, Torisu K, Kamihara Y, Hashizume K, Ichimura K, Yoshino T, Tani Y.

Appl Immunohistochem Mol Morphol. 2008 Jan;16(1):87-93.

PMID:
18091313
26.

Hematopoietic tissue-specific expression of mouse Neil3 for endonuclease VIII-like protein.

Torisu K, Tsuchimoto D, Ohnishi Y, Nakabeppu Y.

J Biochem. 2005 Dec;138(6):763-72.

PMID:
16428305
27.

Characterization of the structure and expression of mouse Itpa gene and its related sequences in the mouse genome.

Behmanesh M, Sakumi K, Tsuchimoto D, Torisu K, Ohnishi-Honda Y, Rancourt DE, Nakabeppu Y.

DNA Res. 2005 Feb 28;12(1):39-51. Erratum in: DNA Res. 2015 Apr;22(2):181.

PMID:
16106751
28.

Development of a prostaglandin D2 receptor antagonist: discovery of a new chemical lead.

Torisu K, Kobayashi K, Iwahashi M, Egashira H, Nakai Y, Okada Y, Nanbu F, Ohuchida S, Nakai H, Toda M.

Eur J Med Chem. 2005 May;40(5):505-19.

PMID:
15893024
29.

Discovery of a new class of potent, selective, and orally active prostaglandin D2 receptor antagonists.

Torisu K, Kobayashi K, Iwahashi M, Nakai Y, Onoda T, Nagase T, Sugimoto I, Okada Y, Matsumoto R, Nanbu F, Ohuchida S, Nakai H, Toda M.

Bioorg Med Chem. 2004 Oct 15;12(20):5361-78.

PMID:
15388164
30.

Development of prostaglandin D2 receptor antagonist: discovery of highly potent antagonists.

Torisu K, Kobayashi K, Iwahashi M, Nakai Y, Onoda T, Nagase T, Sugimoto I, Okada Y, Matsumoto R, Nanbu F, Ohuchida S, Nakai H, Masaaki Toda.

Bioorg Med Chem. 2004 Sep 1;12(17):4685-700.

PMID:
15358295
31.

Discovery of new chemical leads for prostaglandin D2 receptor antagonists.

Torisu K, Kobayashi K, Iwahashi M, Egashira H, Nakai Y, Okada Y, Nanbu F, Ohuchida S, Nakai H, Toda M.

Bioorg Med Chem Lett. 2004 Sep 6;14(17):4557-62.

PMID:
15357992
32.

Discovery of orally active prostaglandin D2 receptor antagonists.

Torisu K, Kobayashi K, Iwahashi M, Nakai Y, Onoda T, Nagase T, Sugimoto I, Okada Y, Matsumoto R, Nanbu F, Ohuchida S, Nakai H, Toda M.

Bioorg Med Chem Lett. 2004 Oct 4;14(19):4891-5.

PMID:
15341946
33.

MRI of anterior cruciate ligament healing.

Ihara H, Miwa M, Deya K, Torisu K.

J Comput Assist Tomogr. 1996 Mar-Apr;20(2):317-21.

PMID:
8606246
34.

[Synthesis of thiazolo[3,2-a]pyridine derivatives and their reactions].

Matsuda Y, Matsumoto H, Ide S, Furuno K, Torisu K, Itou T, Motokawa C.

Yakugaku Zasshi. 1993 Jan;113(1):32-9. Japanese.

PMID:
8463955

Supplemental Content

Loading ...
Support Center